📉 CARE Ratings Delivers Solid Q3 FY26 Performance
CARE Ratings Limited has announced unaudited financial results for Q3 FY26 and 9M FY26, showcasing robust year-on-year growth across key financial metrics. The company's performance was underpinned by stable rating volumes and diversified contributions from its non-ratings businesses, painting a picture of resilience amidst a mixed domestic debt market.
The Numbers:
- Standalone Performance (Q3 FY26): Revenue from operations surged by 15% YoY to ₹90.24 Crores. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) saw a significant 23% YoY increase, reaching ₹37.23 Crores, with margins expanding to 41%. Profit After Tax (PAT) grew by 22% YoY to ₹36.06 Crores, maintaining a healthy 35% margin.
- Nine-Month Performance (9M FY26): Standalone revenue rose 14% YoY to ₹280.15 Crores. EBITDA increased 18% YoY to ₹129.50 Crores, with margins holding strong at 46%. PAT for the nine-month period was up 17% YoY to ₹121.01 Crores (38% margin).
- Consolidated Performance (Q3 FY26): Consolidated revenue climbed 16% YoY to ₹112.12 Crores. EBITDA jumped 33% YoY to ₹40.34 Crores (36% margin). Consolidated PAT grew 29% YoY to ₹36.54 Crores (29% margin).
- Consolidated Performance (9M FY26): Revenue increased 17% YoY to ₹342.40 Crores. EBITDA grew 27% YoY to ₹136.64 Crores (40% margin). PAT rose 24% YoY to ₹120.25 Crores (32% margin).
Management Commentary and Outlook:
Mehul Pandya, Managing Director & Group CEO of CareEdge, highlighted the company's healthy performance despite a challenging domestic debt market. He emphasized evaluating financial performance on an annual basis. The outlook remains cautiously optimistic, supported by anticipated improvements in credit demand, continued healthy capital market activity, and a steadfast focus on governance and analytical rigour. The growth in consolidated revenue is notably buoyed by the non-ratings segments.
Economic and Market Context:
The broader Indian economic landscape shows resilience, with projected real GDP growth of 7.4% for FY26 and 7.2% for FY27. Positive developments like the India-US trade deal are expected to benefit exports. While corporate bond issuances saw a dip of 11.1% YoY in Q3 FY26, commercial paper issuances remained robust, growing 10.3% YoY in 9M FY26. Bank credit offtake accelerated to 14.5% as of December 2025, indicating a supportive financial environment.
The So What?:
CARE Ratings is demonstrating consistent top-line and bottom-line growth, driven by both its core rating business and strategic diversification. The company appears well-positioned to capitalize on improving economic conditions and credit activity, while its management's cautious optimism suggests a measured approach to future growth. Investors should monitor the contributions from non-ratings businesses and the overall health of the credit market for continued performance.